Gao F, Lu G C, Zhou X Y, Yu Z, Wang H M, Bian T
Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Jiangsu, China.
Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Jiangsu, China
Genet Mol Res. 2014 Aug 7;13(3):6135-41. doi: 10.4238/2014.August.7.29.
Pulmonary alveolar proteinosis (PAP) is a rare clinical syndrome that was first described in 1958. To date, whole-lung lavage (WLL) is still the gold-standard therapy for PAP. Herein, we report the case of a male patient who was diagnosed with PAP by open-lung biopsy 8 years prior to presentation at our clinic. The man underwent his first WLL in 2004 and showed marked clinical and radiological improvement after the operation. However, after his original presentation, proteinaceous material continued to accumulate in his lungs. Lavage was performed four additional times, but these attempts failed to arrest the decline in pulmonary function. Each lavage resulted in significant, although transient, clinical improvement.
肺泡蛋白沉积症(PAP)是一种罕见的临床综合征,于1958年首次被描述。迄今为止,全肺灌洗(WLL)仍是PAP的金标准治疗方法。在此,我们报告一例男性患者,该患者在到我院就诊前8年经开胸肺活检被诊断为PAP。该男子于2004年接受了首次全肺灌洗,术后临床和影像学表现均有明显改善。然而,在其首次就诊后,肺部继续有蛋白质物质积聚。又进行了4次灌洗,但这些尝试均未能阻止肺功能的下降。每次灌洗虽带来了显著但短暂的临床改善。